LakeShore Biopharma Co., Ltd. Quarterly Liabilities and Equity in USD from Q1 2023 to Q1 2025

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
LakeShore Biopharma Co., Ltd. quarterly Liabilities and Equity history and growth rate from Q1 2023 to Q1 2025.
  • LakeShore Biopharma Co., Ltd. Liabilities and Equity for the quarter ending March 31, 2025 was $191M, a 10.7% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 $191M -$22.7M -10.7% Mar 31, 2025 20-F 2025-07-31
Q1 2024 $213M -$37M -14.8% Mar 31, 2024 20-F 2024-08-15
Q1 2023 $250M Mar 31, 2023 20-F 2023-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.